ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 4 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,427,500 | +106.3% | 25,000 | +121.2% | 0.02% | +114.3% |
| Q2 2023 | $2,146,322 | -6.0% | 11,300 | -0.9% | 0.01% | -12.5% |
| Q1 2023 | $2,283,648 | -88.9% | 11,400 | -86.8% | 0.01% | -83.3% |
| Q4 2022 | $20,532,960 | -5.8% | 86,400 | -20.7% | 0.05% | +11.6% |
| Q3 2022 | $21,797,000 | -6.7% | 108,900 | -32.0% | 0.04% | +16.2% |
| Q2 2022 | $23,351,000 | +71.3% | 160,100 | +91.7% | 0.04% | +164.3% |
| Q1 2022 | $13,635,000 | +27.8% | 83,500 | +32.8% | 0.01% | +55.6% |
| Q4 2021 | $10,667,000 | -33.0% | 62,900 | -25.4% | 0.01% | -47.1% |
| Q3 2021 | $15,917,000 | -10.7% | 84,300 | -19.9% | 0.02% | -22.7% |
| Q2 2021 | $17,834,000 | +1499.5% | 105,200 | +1231.6% | 0.02% | +1000.0% |
| Q1 2021 | $1,115,000 | -69.0% | 7,900 | -71.5% | 0.00% | -66.7% |
| Q4 2020 | $3,600,000 | +437.3% | 27,700 | +502.2% | 0.01% | +200.0% |
| Q3 2020 | $670,000 | -80.3% | 4,600 | -80.0% | 0.00% | -87.5% |
| Q2 2020 | $3,407,000 | -25.5% | 23,000 | -45.2% | 0.02% | -56.8% |
| Q1 2020 | $4,572,000 | -74.3% | 42,000 | -72.8% | 0.04% | -69.4% |
| Q4 2019 | $17,759,000 | +84.5% | 154,200 | +28.8% | 0.12% | +55.1% |
| Q3 2019 | $9,626,000 | +2603.9% | 119,700 | +2342.9% | 0.08% | +2500.0% |
| Q2 2019 | $356,000 | -42.3% | 4,900 | -25.8% | 0.00% | -57.1% |
| Q1 2019 | $617,000 | -44.0% | 6,600 | -56.3% | 0.01% | -30.0% |
| Q4 2018 | $1,101,000 | -83.5% | 15,100 | -80.2% | 0.01% | -81.1% |
| Q3 2018 | $6,687,000 | +188.9% | 76,400 | +225.1% | 0.05% | +165.0% |
| Q2 2018 | $2,315,000 | -73.4% | 23,500 | -67.9% | 0.02% | -77.3% |
| Q1 2018 | $8,706,000 | +21.1% | 73,100 | +29.2% | 0.09% | +72.5% |
| Q4 2017 | $7,191,000 | -68.2% | 56,600 | -70.6% | 0.05% | -75.1% |
| Q3 2017 | $22,593,000 | +194.1% | 192,300 | +99.7% | 0.20% | +156.2% |
| Q2 2017 | $7,681,000 | +175.0% | 96,300 | +76.7% | 0.08% | +142.4% |
| Q1 2017 | $2,793,000 | +37.1% | 54,500 | +0.2% | 0.03% | +65.0% |
| Q4 2016 | $2,037,000 | -58.9% | 54,400 | -25.6% | 0.02% | -63.0% |
| Q3 2016 | $4,955,000 | +48.8% | 73,100 | +21.8% | 0.05% | +38.5% |
| Q2 2016 | $3,329,000 | +104.0% | 60,000 | +130.8% | 0.04% | +69.6% |
| Q1 2016 | $1,632,000 | +19.6% | 26,000 | +79.3% | 0.02% | +43.8% |
| Q4 2015 | $1,365,000 | -50.3% | 14,500 | -57.6% | 0.02% | -57.9% |
| Q3 2015 | $2,748,000 | -18.7% | 34,200 | +21.3% | 0.04% | -19.1% |
| Q2 2015 | $3,380,000 | -27.9% | 28,200 | -37.2% | 0.05% | -36.5% |
| Q1 2015 | $4,688,000 | +67.2% | 44,900 | +55.4% | 0.07% | +76.2% |
| Q4 2014 | $2,803,000 | +754.6% | 28,900 | +588.1% | 0.04% | +740.0% |
| Q3 2014 | $328,000 | -62.9% | 4,200 | -70.0% | 0.01% | -64.3% |
| Q2 2014 | $884,000 | -33.2% | 14,000 | -28.9% | 0.01% | -36.4% |
| Q1 2014 | $1,323,000 | +254.7% | 19,700 | +239.7% | 0.02% | +266.7% |
| Q4 2013 | $373,000 | -49.3% | 5,800 | -49.6% | 0.01% | -57.1% |
| Q3 2013 | $736,000 | +51.1% | 11,500 | -26.8% | 0.01% | +16.7% |
| Q2 2013 | $487,000 | – | 15,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 57 | $741,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 27,700 | $3,600,000 | 0.01% |
| SIMPLEX TRADING, LLC | 104 | $1,351,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |